| RS1591141963 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1591142078 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1591142418 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1591142530 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1591142727 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591150359 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591150887 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1591151199 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1591151390 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1591151678 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Ataxia-telangiectasia syndrome |
| RS1591151905 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1591152021 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1591156543 |
MMP13
|
Health Risk |
Likely pathogenic |
— |
| RS1591158999 |
RDX
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 24, Autosomal recessive nonsyndromic hearing loss 24 |
| RS1591159614 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591159924 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1591160284 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591160295 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1591161290 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1591161470 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1591161769 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1591161831 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591167422 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1591167598 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1591171040 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1591171790 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591172641 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1591177953 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1591178022 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1591178362 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1591178998 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1591179199 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1591183992 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591184471 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1591184927 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS1591186383 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS1591190908 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1591191412 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591191449 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1591192055 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591192266 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1591192550 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591192583 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591197705 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591199097 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS1591224147 |
MYO7A
|
Health Risk |
Likely pathogenic |
Autosomal dominant nonsyndromic hearing loss 11, Autosomal dominant nonsyndromic hearing loss 11 |
| RS1591234203 |
ALKBH8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder, autosomal recessive 71 |
| RS1591246507 |
FOLR1
|
Health Risk |
Pathogenic |
Cerebral folate transport deficiency, Cerebral folate transport deficiency |
| RS1591247825 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, ATM-related cancer predisposition |
| RS1591249094 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1591249359 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1591249480 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1591263883 |
IL10RA
|
Health Risk |
Pathogenic |
Inflammatory bowel disease 28, Inflammatory bowel disease 28 |
| RS1591264194 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1591265186 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1591266263 |
KMT2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Wiedemann-Steiner syndrome, Inborn genetic diseases |
| RS1591266379 |
BEST1
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 2, Vitelliform macular dystrophy 2 |
| RS1591266591 |
BEST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS1591267688 |
ALKBH8
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder, autosomal recessive 71 |
| RS1591268116 |
FAR1
|
Health Risk |
Likely pathogenic |
Fatty acyl-CoA reductase 1 deficiency, Fatty acyl-CoA reductase 1 deficiency |
| RS1591269240 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591273850 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1591274370 |
KMT2A
|
Health Risk |
Likely pathogenic |
— |
| RS1591274530 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1591274900 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591277785 |
MYO7A
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS1591278347 |
CD3D
|
Health Risk |
Pathogenic |
Immunodeficiency 19, Immunodeficiency 19 |
| RS1591280478 |
BEST1
|
Health Risk |
Likely pathogenic |
Vitelliform macular dystrophy 2, Vitelliform macular dystrophy 2 |
| RS1591280714 |
BEST1
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 2, Vitelliform macular dystrophy 2 |
| RS1591281225 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591281317 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591281522 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591281736 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591282224 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1591282615 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1591283017 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, KMT2A-related disorder |
| RS1591283372 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1591283456 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591283716 |
DYNC2H1
|
Health Risk |
Pathogenic |
Jeune thoracic dystrophy, Jeune thoracic dystrophy |
| RS1591283793 |
BEST1
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 2, Vitelliform macular dystrophy 2 |
| RS1591283811 |
BEST1
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 2, Vitelliform macular dystrophy 2 |
| RS1591284015 |
BEST1
|
Health Risk |
Pathogenic |
— |
| RS1591284563 |
BEST1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive bestrophinopathy, BEST1-related disorder |
| RS1591285040 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591285326 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591285545 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591286221 |
MYO7A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS1591286581 |
KMT2A
|
Health Risk |
Pathogenic |
Wiedemann-Steiner syndrome, Wiedemann-Steiner syndrome |
| RS1591286671 |
MYO7A
|
Health Risk |
Pathogenic |
Usher syndrome type 1, Usher syndrome type 1 |
| RS1591286958 |
KMT2A
|
Health Risk |
Pathogenic |
— |
| RS1591287317 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Autosomal recessive nonsyndromic hearing loss 2 |
| RS1591292118 |
KMT2A
|
Health Risk |
Pathogenic |
KMT2A-related disorder, KMT2A-related disorder |
| RS1591295182 |
BEST1
|
Health Risk |
Pathogenic |
— |
| RS1591299252 |
C1QTNF5
|
Health Risk |
Pathogenic/Likely pathogenic |
Late-onset retinal degeneration, Late-onset retinal degeneration |
| RS1591301548 |
BEST1
|
Health Risk |
Pathogenic |
Vitelliform macular dystrophy 2, Autosomal dominant vitreoretinochoroidopathy |
| RS1591302809 |
MFRP
|
Health Risk |
Pathogenic |
— |
| RS1591303900 |
BEST1
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1591306315 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1591307438 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS1591310948 |
MYO7A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 2, Ear malformation |